Two Sigma Investments’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21,111
Closed -$35.5K 3364
2022
Q4
$35.5K Buy
+21,111
New +$118K ﹤0.01% 2630
2022
Q1
Sell
-473
Closed -$10K 4811
2021
Q4
$10K Buy
+473
New +$16K ﹤0.01% 4185
2021
Q3
Sell
-8,485
Closed -$525K 4951
2021
Q2
$525K Buy
8,485
+1,942
+30% +$176K ﹤0.01% 3052
2021
Q1
$687K Buy
6,543
+1,857
+40% +$254K ﹤0.01% 2647
2020
Q4
$665K Buy
4,686
+2,116
+82% +$226K ﹤0.01% 2299
2020
Q3
$191K Buy
+2,570
New +$200K ﹤0.01% 2835

Other funds holding ONCS

Two Sigma Investments's ONCS Position: Q1 2023 in Review

Two Sigma Investments sold out of OncoSec Medical Incorporated (ONCS) in Q1 2023, closing a stake of 21,111 shares — an estimated $35.5K sold.

Two Sigma Investments first reported a position in ONCS in Q3 2020 and held it in 6 quarters. The position peaked at $687K in Q1 2021. 12 funds tracked by Wall St. Rank hold ONCS as of Q1 2023.

  • Two Sigma Investments reported no remaining OncoSec Medical Incorporated position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Investments sold 21,111 OncoSec Medical Incorporated shares in Q1 2023, an estimated $35.5K.
  • Two Sigma Investments first reported a position in OncoSec Medical Incorporated in Q3 2020 and held it in 6 quarters.
  • Two Sigma Investments's OncoSec Medical Incorporated position peaked at $687K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.